The concentration of extract, which could neutralize 50% of the free radicals generated from 2.2-diphenyl-1-picrylhydrazyl of medicinal materials, after processing was 53.71 ± 0.44 μg / ml, about 2.3 times lower when compared to raw pharmaceutical materials (124, 38 ± 0, 56 μg / ml).